Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease

Br J Urol. 1998 May;81(5):666-71; discussion 671-2. doi: 10.1046/j.1464-410x.1998.00620.x.

Abstract

Objective: To determine whether urinary prothrombin fragment 1 (UPTF1), which shows considerable promise as a critical determinant of calcium oxalate (CaOx) stone formation, is manufactured by the human kidney.

Materials and methods: Ribonucleic acid was isolated from eight kidneys, two spleens and one liver. Using reverse transcriptase-polymerase chain reaction, mRNA corresponding to the UPTF1 portion of prothrombin was analysed by agarose-gel electrophoresis and Southern blotting.

Results: Six kidney specimens showed clear evidence of prothrombin gene expression; expression in the kidney was less than that in the liver.

Conclusion: This is the first demonstration of prothrombin gene expression within the human kidney, a finding that not only has implications for CaOx stone disease but also potentially for blood coagulation.

MeSH terms

  • Biomarkers
  • Blotting, Southern
  • Calcium Oxalate / metabolism
  • Gene Expression
  • Humans
  • Kidney Calculi / metabolism*
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism*
  • Polymerase Chain Reaction
  • Protein Precursors / genetics
  • Protein Precursors / metabolism*
  • Prothrombin / genetics
  • Prothrombin / metabolism*
  • RNA, Messenger / metabolism

Substances

  • Biomarkers
  • Peptide Fragments
  • Protein Precursors
  • RNA, Messenger
  • Calcium Oxalate
  • prothrombin fragment 1
  • Prothrombin